Telmisartan for Treatment of COVID-19 Patients

NCT04355936 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19 Drug Treatment

Interventions

DRUG: Telmisartan arm will receive 80 mg Telmisartan twice daily plus standard care.

Sponsor

Laboratorio Elea Phoenix S.A.

Collaborators

[object Object]
[object Object]